Disinfectants and antiseptics may be increasing the antibiotic resistance of a superbug

Publicly released:
Australia; NSW; VIC
Image by Ri Butov from Pixabay
Image by Ri Butov from Pixabay

Disinfectants, also known as biocides, may be worsening the ability of antibiotics to fight a superbug called Acinetobacter baumannii, a multi-drug resistant, hospital-acquired bacteria that causes serious wound, bloodstream and lung infections, according to Australian and UK research. The researchers found that that low levels of certain biocides, including chlorhexidine which is often used for skin disinfection before surgery, could alter processes inside the bacteria's cells and these changes could help it survive and grow when exposed to multiple different types of antibiotics. The authors conclude that low levels of biocides remaining in the environment due to their widespread use might promote antibiotic tolerance and resistance in harmful bacteria.

Media release

From: Springer Nature

Microbiology: Biocides could promote antibiotic tolerance in Acinetobacter baumannii

Related documents (1)

Full text: Cain 41564_2023_Article_1474.pdf (10.3 MB)

Low levels of commonly used biocides, such as disinfectants and antiseptics, may increase antibiotic tolerance in Acinetobacter baumannii, a multi-drug resistant, hospital-acquired pathogen that causes serious wound, bloodstream and lung infections. This bacterium is known to cause infections in the blood, urinary tract and lungs (pneumonia), or in wounds in other parts of the body. The findings, published in Nature Microbiology, suggest that residual levels of biocides might exacerbate antibiotic tolerance and resistance.

Biocides — such as bleach, alcohol and silver nitrate — are chemicals commonly used in households, hospitals and many other environments to kill bacteria and other microorganisms. However, currently little is known about how they kill bacteria. There have been concerns about whether widespread and unregulated use could contribute to the development of antibiotic resistance in important human pathogens, such as A. baumannii.

Ian Paulsen, Amy Cain and colleagues used genetic screening to look for bacterial genes that either increase or decrease A. baumannii sensitivity to ten clinically relevant biocides. They found that certain biocides, including chlorhexidine and benzalkonium, affected fundamental bacterial processes and can act inside the cell rather than predominantly targeting the cell surface, as suggested in previous research. A. baumannii was found to respond to low levels of these toxic compounds, specifically chlorhexidine and benzalkonium, and these changes could help it survive and grow when exposed to multiple different types of antibiotics.

The authors conclude that low levels of biocides remaining in the environment due to their widespread use might promote antibiotic tolerance and resistance in pathogenic bacteria.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Springer Nature, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference:
Nature Microbiology
Research:Paper
Organisation/s: Macquarie University, Monash University, The University of Newcastle, University of Technology Sydney (UTS)
Funder: This work was supported by NHMRC (National Health and Medical Research Council) project grants APP1127615, APP1060895 and APP1165135 to I.T.P. and K.A.H. This work was also supported by ARC (Australian Research Council) Centre of Excellence in Synthetic Biology grant CE200100029 to I.T.P. The sequencing was supported by Wellcome Trust grant WT098051. Construction of the transposon mutant library was supported by Wellcome Trust grant WT100087/ Z/12/Z. I.T.P. was supported by ARC Laureate Fellowship FL140100021. A.K.C. was supported by ARC DECRA (Discovery Early Career Research Award) Fellowship DE180100929. F.L.S. was supported by ARC DECRA Fellowship DE200101524. K.A.H. was supported by ARC Future Fellowship FT180100123.
Media Contact/s
Contact details are only visible to registered journalists.